L
Lalita
About Lalita
Data last updated:
Lalita is a Director at Hrp Pharma Private Limited (since 2021) and Director at Health Rise Pharma India Private Limited (since 2015). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹37.56 Cr; the largest is Hrp Pharma Private Limited at ₹37.07 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Hrp Pharma Private Limited U51909HR2021PTC095647 | Director | 17 Jun 2021 | 2021 | ₹37.07 Cr (FY 2024) | Active |
| Health Rise Pharma India Private Limited U74900HR2015PTC054933 | Director | 19 Mar 2015 | 2015 | ₹48.2 Lakh (FY 2022) | Active |
Board colleagues of Lalita
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sachin Popli | 07094028 | Hrp Pharma Private Limited , Health Rise Pharma India Private Limited | Director |
| Parveen Kumar Mangla | Health Rise Pharma India Private Limited | Cfo | |
| Parveen Kumar Mangla | 09072901 | Health Rise Pharma India Private Limited | Cfo |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Lalita
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lalita
Lalita currently holds 2 directorships: Hrp Pharma Private Limited (Director, since 17 Jun 2021, revenue ₹37.07 Cr (FY 2024)); Health Rise Pharma India Private Limited (Director, since 19 Mar 2015, revenue ₹48.2 Lakh (FY 2022)).
Lalita was first appointed on 19 Mar 2015 as Director at Health Rise Pharma India Private Limited. The most recent appointment on record is 17 Jun 2021 at Hrp Pharma Private Limited.
The 2 current companies of Lalita that report revenue have a combined latest revenue of ₹37.56 Cr: Hrp Pharma Private Limited ₹37.07 Cr (FY 2024); Health Rise Pharma India Private Limited ₹48.2 Lakh (FY 2022).
The current boards of Lalita's companies include Sachin Popli (Hrp Pharma Private Limited), Parveen Kumar Mangla (Health Rise Pharma India Private Limited), Parveen Kumar Mangla (Health Rise Pharma India Private Limited).